Published date: 24 May 2021
Last edited date: 13 August 2021
This notice was replaced on 1 October 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Future opportunity (published 1 October 2021)
Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.
Contract summary
Industry
Vaccines - 33651600
Location of contract
SE1 8UG
Value of contract
£0
Procurement reference
CF-0209300D0O000000rwimUAA3
Published date
24 May 2021
Approach to market date
4 October 2021
Contract start date
1 August 2022
Contract end date
31 July 2024
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of pneumococcal conjugate vaccine to be used as part of the national
childhood immunisation programme. The contracting authority estimates their requirement for deliveries between 1 August 2022 to 31 July 2024 ('Initial Term') of the contract to be 1,440,000 courses of vaccine, with the option to extend for up to an additional 24 months.
More information
Previous notice about this procurement
Pneumococcal conjugate vaccine
- Future opportunity
- Published 24 May 2021, last edited 12 August 2021
About the buyer
Contact name
Lynne Nichols
Address
2nd Floor, Rutland House
Runcorn
WA7 2ES
GB
Share this notice